ALNY EPS Estimates
Alnylam Pharmaceuticals, Inc.
$156.61
+$0.67(+0.43%)
29
Overall
20
Value
18
Tech
50
Quality
Market Cap
$20.98B
Volume
3.30M
52W Range
$154.30 - $479.79
Target Price
$312.23
ALNY EPS estimates: the consensus estimate for Alnylam Pharmaceuticals, Inc.'s current fiscal year is $6.85 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ALNY EPS Estimates
- EPS estimate, current quarter
- $1.68
- EPS estimate, next quarter
- $1.76
- EPS estimate, current year
- $6.85
- EPS estimate, next year
- $8.14
- EPS growth, 3-year
- +31.17%
| Fiscal year | EPS |
|---|---|
| 2025 | $2.39 |
| 2024 | $-2.18 |
| 2023 | $-3.52 |
| 2022 | $-9.30 |
| 2021 | $-7.20 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $156.61 | +0.4% | 3.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW